Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Feb 3;6(2):e30.
doi: 10.1371/journal.pmed.1000030.

Neglected disease research and development: how much are we really spending?

Mary Moran  1 , Javier Guzman, Anne-Laure Ropars, Alina McDonald, Nicole Jameson, Brenda Omune, Sam Ryan, Lindsey Wu
Affiliations

Neglected disease research and development: how much are we really spending?

Mary Moran et al. PLoS Med. .

Abstract

Mary Moran and colleagues survey global investment into research and development of new pharmaceutical products to prevent, manage, or cure diseases of the developing world.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: MM, the lead author, has acted as an advisor or Expert Committee member to several of the groups mentioned in the report, including the World Health Organization, the Wellcome Trust, the European Commission, and Merck. This has sometimes involved payment of an honorarium or of travel and accommodation. MM, JG, and A-LR have also previously received research grants from the Wellcome Trust, the Global Forum for Health Research, and the International AIDS Vaccine Initiative. The remaining authors declare that they have no competing interests.

Figures

Figure 1
Figure 1. Three-Step Filter To Determine Scope of Neglected Diseases Covered by G-FINDER
Figure 2
Figure 2. HIV/AIDS R&D Funding in 2007
Figure 3
Figure 3. Malaria R&D Funding in 2007
Figure 4
Figure 4. TB R&D Funding in 2007
Figure 5
Figure 5. Total R&D Funding by Funder Type in 2007
See this image and copyright information in PMC

References

    1. Hotez P, Molyneux DH, Fenwich A, Kumaresan J, Sachs SE, et al. Control of neglected tropical diseases. N Engl J Med. 2007;357:1018–1026. - PubMed
    1. Toreele E, Usdin M, Chirac P. A needs-based pharmaceutical R&D agenda for neglected diseases. World Health Organization. 2004. p. 12. Available: http://www.who.int/intellectualproperty/topics/research/Needs%20based%20.... Accessed 30 December 2008.
    1. IJsselmuiden C, de Haan S, Iacono SL, Kisia CN, Moomal H. Alignment and harmonisation in health research: AHA study. Council for Health Research for Development. 2008. pp. 29–39. Available: http://www.cohred.org/AHA/files/resources/Synthesis_web.pdf. Accessed 30 December 2008.
    1. Currat LJ, de Francisco A, Al-Tuwaijri S, Ghaffar A, Jupp S. Progress in measuring the 10/90 gap. Global Forum for Health Research. 2004. pp. 107–126. Available: http://www.globalforumhealth.org/filesupld/1090_report_03_04/109004_chap.... Accessed 30 December 2008.
    1. HIV Vaccines and Microbicides Resource Tracking Working Group. Sustaining the HIV prevention research agenda: Funding for research and development of HIV vaccines, microbicides, and other new prevention options 2000–2007. 2008. pp. 1–38. Available: http://hivresourcetracking.org/content/RT_report_August2008.pdf. Accessed 30 December 2008.

Publication types